Pliant Therapeutics Inc (PLRX) — Capital Reinvestment Ratio

Latest as of June 2020: 0.04x

Pliant Therapeutics Inc (PLRX) has a Capital Reinvestment Ratio of 0.04x as of June 2020, meaning it reinvests 0% of its operating cash flow ($7.77 Million) in capital expenditures ($286.00K). See PLRX equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.04x

Capex / Operating Cash Flow

Operating Cash Flow

$7.77 Million

USD

Capital Expenditures

$286.00K

USD

Data as of

Jun 2020

Most recent filing

Annual Capital Reinvestment Ratio for Pliant Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Pliant Therapeutics Inc from None to None. For live market cap and broader valuation context, see Pliant Therapeutics Inc (PLRX) market capitalisation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow